David Hutton, PhD
Dr. Hutton is an assistant professor of health management and policy in the School of Public Health who focuses on health policy modeling and cost-effectiveness analysis.
Initiatives:
Economics of Eye Care
ECONOMICS OF EYE CARE
Economics of Eye Care researchers at the Kellogg Eye Center are working to make the delivery of eye care more efficient and cost-effective.
Roni M. Shtein, MD, MS
Dr. Shtein is a cornea specialist interested in the cost-effectiveness of different treatments for corneal disease.
Initiatives:
Lindsey B. De Lott, MD
Dr. De Lott is a neuro-ophthalmologist who focuses her research on resource utilization and telemedicine approaches to early, remote diagnosis of optic nerve and eye movement disorders
Initiatives:
Recent Publications
Joshua D. Stein, MD, MS
Dr. Stein is a glaucoma specialist with expertise in research using large data sets to understand important associations with ocular diseases and to study the economics of eye care.
Initiatives:
Recent Publications
In the News
Switching to less expensive blindness drug could save Medicare Part B $18 billion over a ten-year period
June, 2014
The biologic drugs bevacizumab and ranibizumab have revolutionized treatment of diabetic macular edema and neovascular age-related macular degeneration.
Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration
April, 2014
PURPOSE: We sought to determine the most cost-effective treatment for patients with newly diagnosed neovascular macular degeneration: monthly or as-needed bevacizumab injections, o
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema
September, 2013
OBJECTIVE: Anti–vascular endothelial growth factor therapies have revolutionized the treatment of clinically significant diabetic macular edema (CSDME); yet these agents are expens
Comparative cost-effectiveness analysis of Descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States
January, 2013
PURPOSE: To perform a comparative cost-effectiveness analysis of Descemet stripping automated endothelial keratoplasty (DSAEK) and penetrating keratoplasty (PK) for corneal endothe
Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma
April, 2012
OBJECTIVE: To determine the most cost-effective treatment option for patients with newly diagnosed mild open-angle glaucoma: observation only, treatment with generic topical prosta